Latest Business News

 

Shutterstock 222259255

Arkema invests in speciality chemicals

13 July 2017

Company will expand Asian plants producing bio-based polyamide, thiochemicals and photocured resins

Pile of pills drugs medicine bottle

Mallinckrodt settles US opioid lawsuit

13 July 2017

Firm will pay $35m over allegations it failed to report suspicious orders of controlled substances

Sickle cell disease

FDA approves first sickle cell drug in almost two decades

10 July 2017

Glutamine-based drug is the first approved for children over 5

Mergers and acquisitions shutterstock 60635239

EU to investigate Merck KGaA’s merger with Sigma–Aldrich

10 July 2017

Commission says Merck failed to disclose a crucial research project

Long reads

Entrepreneurial spirit

How to become a science entrepreneur

By

Five tips from the experts on going it alone

Andrew Hopkins of Exscientia

Amplifying intelligent drug design

By

This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK

Estimated TB incidence rates 2015 data  - Hero

Access to drugs: a failure of pharma?

By

Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates

More

Profiles

Research and development at Sugru

The glue entrepreneurs

By Rachel Brazil

The business novices who launched global sticky success Sugru

Andrew Hopkins of Exscientia

Amplifying intelligent drug design

By

This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK

MedImmune laboratory

Expanding precision medicine beyond cancer

By

Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune

Peter Seeberger

Taming vaccines with chemistry

By

Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules

More

Opinion

132232 Figure 1

(+)-Pleuromutilin

By

Total synthesis is sometimes the only way to explore the chemical space around a natural product

0817CW - In the Pipeline - Needles in the haystack - Main

Making enough of a difference

By

What if the needle in the drug development haystack ends up being too small to be useful?

0717CW - Business Leader - Bottle neck concept illustration

What's holding back continuous manufacturing?

By

Despite manay advantages, the move to flow chemistry in fine and speciality chemicals is slow

Biotrail building in Rennes, France

Unpicking a clinical trial death

By

A new study shows up off-target effects of a drug that proved deadly, and highlights the pitfalls of drug discovery

More

More Business News

artistic rendering of an anitbody molecule

Celgene and BeiGene agree cancer partnership

7 July 2017By

Immuno-oncology deal sees firms exchange licensing rights for antibody drugs

RNA

Silence Therapeutics and Alnylam in patent dispute

5 July 2017By

Suit alleges competitors need to license Silence patents relating to their drug cantidates

Volodymyr Groysman with the Ukranian cabinet of ministers

Ukraine plans to privatise state chemical producers

29 June 2017By

Government aims to develop struggling industry by attracting foreign investment

maize corn growing in a field

GM corn growers win US lawsuit against Syngenta

26 June 2017By

Kansas jury awards over $217m damages to farmers in the first of eight trials

Pharmacy shelves

FDA asks Endo to take pain drug off market

15 June 2017By

Request part of larger strategy to address opioid misuse in the US

An image of a firefighter tackling a large blaze

Explosion kills 10 at Chinese petrochemical plant

9 June 2017By

Nine others injured when gas tanker exploded in loading area